Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 79

Sort by

Sort Order Select

Journal Articles

Macrophage Hypercellularity Accompanies Erythroid Hyperplasia in Sickle Cell Mice and during Recovery from Blood Loss in Wild Type Mice

Oluwabukola Gbotosho, BSc, MSc, PhD, Maria G Kapetanaki, PhD, Samit Ghosh, Frances Weidert, MS, Grant C. Bullock, MD PhD, Solomon Fiifi Ofori-Acquah, Gregory J Kato, MD

Blood (2019) 134 (Supplement_1): 3528.

https://doi.org/10.1182/blood-2019-127224

Published: 2019

Journal Articles

Codanin-1 Mutations Engineered in Human Erythroid Cells Allow Investigation of Mechanisms Underlying Congenital Dyserythropoietic Anemia

Zachary C. Murphy, PhD, Michael Getman, MS, Jacquelyn Lillis, Laurie A. Steiner, MD

Blood (2019) 134 (Supplement_1): 3739.

https://doi.org/10.1182/blood-2019-127415

Published: 2019

Journal Articles

Evolution of Moderate Aplastic Anemia into Subclinical PNH/AA and Successful Treatment with Reduced Intensity Haplo-HSCT: A Pediatric Case Report

Meghana Srinivas, Jennifer Krajewski, MD, Nancy Durning, APN, Melanie Hankewycz, APN, Alfred Gillio, MD

Blood (2019) 134 (Supplement_1): 5027.

https://doi.org/10.1182/blood-2019-130407

Published: 2019

Journal Articles

Clinical and Morphologic Predictors of Outcome in a Multicenter Cohort of ITP Patients Treated with Trombopoietin Analogues

Bruno Fattizzo, MD, Raffaella Pasquale, Monica Carpenedo, Silvia Cantoni, Giuseppe Auteri, MD, Doriana Gramegna, MD, Mariella D'adda, MD, Mariasanta Napolitano, Marco Ruggeri, MD, Sergio Siragusa, MD Professor, Giuseppe Rossi, Nicola Vianelli, MD, Wilma Barcellini, MD

Blood (2018) 132 (Supplement 1): 3764.

https://doi.org/10.1182/blood-2018-99-116627

Published: 2018

Journal Articles

Peroxiredoxin II ( PRDX2 ) Is a Novel Candidate Gene for Congenital Dyserythropoietic Anemia

Myesa Emberesh, MBBS, Katie Giger Seu, PhD, Sana Emberesh, MBBS, Lisa Trump, Mary Risinger, PhD, Wenying Zhang, MD PhD, Ammar Husami, Carolyn Lutzko, PhD, Vinod Gidvani-Diaz, Robert B. Lorsbach, MD PhD, Theodosia A. Kalfa, MD PhD

Blood (2018) 132 (Supplement 1): 3605.

https://doi.org/10.1182/blood-2018-99-120056

Published: 2018

Journal Articles

Conservative Management of Idiopathic Hemophagocytic Lymphohistiocytosis (HLH) Achieving Complete Remission

Jesus C Fabregas, MD, Guiset Carvajal, MD

Blood (2018) 132 (Supplement 1): 4963.

https://doi.org/10.1182/blood-2018-99-112029

Published: 2018

Journal Articles

RUNX1 associated Familial Platelet Disorder with Myeloid Malignancy (FPD-MM) in Children: A Novel New Phenotype with Juvenile and Chronic Myelomonocytic Leukemia (JMML/CMML) Characteristics

Katherine Regling, DO, Shruti Bagla, PhD, Ahmar Urooj Zaidi, MD BSc, Erin Wakeling, PhD, Michael C. Chicka, PhD, Leigh Flores, MD, Manisha Gadgeel, MBBS, MS, Steven Buck, MS, Meera B. Chitlur, MD, Charles A. Schiffer, MD, Yaddanapudi Ravindranath, MBBS

Blood (2018) 132 (Supplement 1): 5504.

https://doi.org/10.1182/blood-2018-99-116925

Published: 2018

Journal Articles

A Rare Case of Pearson's Syndrome with Predominant Hematological Manifestations and Novel Mitochondrial Deletion

Parth Desai, MD MBBS, Annapurna Saksena, MD MBBS, Prasad Sudhir Dange, Richa Gupta, Seema Kapoor, Tejinder Singh

Blood (2017) 130 (Supplement 1): 4958.

https://doi.org/10.1182/blood.V130.Suppl_1.4958.4958

Published: 2017

Journal Articles

Characterization of Iron Metabolism in Mouse Model of Congenital Polycythemia with Human Gain-of-Function Erythropoietin Receptor

Barbora Kralova, MSc, Jihyun Song, PhD, Vladimir Divoky, PhD, Josef T. Prchal, MD, Monika Horvathova, MSc, PhD

Blood (2017) 130 (Supplement 1): 170.

https://doi.org/10.1182/blood.V130.Suppl_1.170.170

Published: 2017

Journal Articles

Germline ERBB2 Variants Associate with Myeloproliferative Neoplasms

Evan M Braunstein, MDPhD, Donna Marie Williams, PhD, Igor Makhlin, MD, Aparna Pallavajjala, Christopher D Gocke, MD, Nara Sobreira, MD, Kala Visvanathan, MD, Linda Resar, MD, Jerry L. Spivak, MD, Alison R. Moliterno, MD

Blood (2017) 130 (Supplement 1): 1663.

https://doi.org/10.1182/blood.V130.Suppl_1.1663.1663

Published: 2017

Journal Articles

Efficacy of Lenalidomide in Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts

Francois Girodon, MD PhD, Alexia Plocque, Laurent Voillat, Julien Broséus, Agnès Guerci

Blood (2017) 130 (Supplement 1): 5317.

https://doi.org/10.1182/blood.V130.Suppl_1.5317.5317

Published: 2017

Journal Articles

Clinical Significance of Myeloblasts Percentage in the De Novo Acute Myeloid Leukemia with Erythroid Hyperplasia

Shaowei Qiu, MD, Hui Wei, MD PhD, Dong Lin, MD PhD, Guangji Zhang, Shuning Wei, Chunlin Zhou, MD PhD, Kaiqi Liu, Ying Wang, MD, Bingcheng Liu, Yuntao Liu, Benfa Gong, Xiaoyuan Gong, MD, Sizhou Feng, Yingchang Mi, MD PhD, Mingzhe Han, Jianxiang Wang, MD

Blood (2016) 128 (22): 5245.

https://doi.org/10.1182/blood.V128.22.5245.5245

Published: 2016

Journal Articles

Therapeutic Outcomes of Patients with Acute Erythroid Leukemia Treated with Hypomethylating Agents

Richard King, MD, Ashley Crouch, B.S., Vedran Radojcic, MD, Bernard Lawrence Marini, PharmD, Anthony J. Perissinotti, PharmD, Dale L. Bixby, MD PhD

Blood (2016) 128 (22): 5203.

https://doi.org/10.1182/blood.V128.22.5203.5203

Published: 2016

Journal Articles

Quantification of Erythroblast- and Myelocyte-Derived mRNAs in Plasma Exosomes As an Indicator of Bone Marrow Status in Patients with Various Types of Anemias and Myeloproliferative Disorders

Masato Mitsuhashi, MD PhD, Taku Murakami, PhD, Teodora Kuzmanovic, Cassandra M. Hirsch, BSc, Hideki Makishima, MD, PhD, Jaroslaw P Maciejewski, MD PhD FACP

Blood (2016) 128 (22): 5070.

https://doi.org/10.1182/blood.V128.22.5070.5070

Published: 2016

Journal Articles

Myelodysplastic Syndromes (MDS) with Erythroid Hyperplasia: Enumerating Blasts from Non-Erythroid Cell Compartment Improves the Risk Stratification of MDS with Excess of Blasts

Leonor Arenillas, MD, Xavier Calvo, MD, Mar Tormo, MD PhD, David Valcárcel, MD PhD, Elisa Luño, MD PhD, Esther Alonso, MD, María Consuelo Cañizo, MD PhD, Fernando Ramos, MD PhD MPH, Carmen Pedro, MD PhD, Beatriz Arrizabalaga, MD, Alicia Bailén, MD, José María Raya, MD, María Teresa Ardanaz, MD, Guillermo Sanz, MD PhD, Lourdes Florensa, MD PhD

Blood (2015) 126 (23): 2894.

https://doi.org/10.1182/blood.V126.23.2894.2894

Published: 2015

Journal Articles

RAEB-1 with Erythroid Hyperplasia and Erythroleukemia Share Clinico-Biological Features and Outcome: A Same Disease with Different Labels?

Xavier Calvo, MD, Leonor Arenillas, MD, Mar Tormo, MD PhD, David Valcárcel, MD PhD, Elisa Luño, MD PhD, Esther Alonso, MD, María Díez-Campelo, MD PhD, Fernando Ramos, MD PhD MPH, Carmen Pedro, MD PhD, Beatriz Arrizabalaga, MD, Alicia Bailén, MD, José María Raya, MD, María Teresa Ardanaz, MD, Guillermo Sanz, MD PhD, Lourdes Florensa, MD PhD

Blood (2015) 126 (23): 2866.

https://doi.org/10.1182/blood.V126.23.2866.2866

Published: 2015

Journal Articles

A Germline Mutation in ERBB3 Predisposes to Inherited Erythroid Myelodysplasia/Erythroleukemia

Evan M. Braunstein, MD PhD, Ruijuan Li, Nara Sobreira, MD, Christopher Gocke, MD, Robert A. Brodsky, MD, David Valle, MD, Linzhao Cheng, PhD

Blood (2015) 126 (23): 4105.

https://doi.org/10.1182/blood.V126.23.4105.4105

Published: 2015

Journal Articles

Long Non-Coding RNA Induces De Novo Myelodysplastic Syndrome through Epigenetic Regulation

Maitri Shah, MS, Valentina Pilecki, Roxana Redis, Linda Fabris, Maria Ciccone, MD, Cristina Ivan, Ioana Berindan-Neago, Riccardo Fodde, Carlos E. Bueso-Ramos, MD, Mihai Gagea, Guillermo Garcia Manero, George Calin, MDPhD

Blood (2015) 126 (23): 1640.

https://doi.org/10.1182/blood.V126.23.1640.1640

Published: 2015

Journal Articles

Biallelic Mutations in PARP4 Are Linked to a Variant Form of Congenital Dyserythropoietic Anemia

Paola Bianchi, PhD, Elisa Fermo, PhD, Jennifer C Eng, Jacob C Ulirsch, Cristina Vercellati, BSc, Paola Braidotti, MD, Gordon Hildick-Smith, Timothy J Satchwell, PhD, Stephanie Pellegrin, PhD, Alberto Zanella, MD, Wilma Barcellini, MD, Barry H. Paw, MD, PhD, Ashley Mark Toye, PhD, Vijay G Sankaran, MD PhD

Blood (2015) 126 (23): 272.

https://doi.org/10.1182/blood.V126.23.272.272

Published: 2015

Journal Articles

Gardos Channel Mutation Is Associated with Hereditary Dehydrate Stomatocytosis: a Complex Channelopathy

Elisa Fermo, PhD, Anna Yu. Bogdanova, Dr PhD, Polina Petkova-Kirova, PhD, Anna Zaninoni, BSc, PhD, Anna Paola Marcello, PhD, Asya Makhro, PhD, Pascal Hänggi, PhD, Laura Hertz, PhD, Jens Danielczok, Nadia Mirra, MD, Alberto Zanella, MD, Wilma Barcellini, MD, Kaestner Lars, PhD, Paola Bianchi, PhD

Blood (2015) 126 (23): 3333.

https://doi.org/10.1182/blood.V126.23.3333.3333

Published: 2015

NARROW

Macrophage Hypercellularity Accompanies Erythroid Hyperplasia in Sickle Cell Mice and during Recovery from Blood Loss in Wild Type Mice

Codanin-1 Mutations Engineered in Human Erythroid Cells Allow Investigation of Mechanisms Underlying Congenital Dyserythropoietic Anemia

Evolution of Moderate Aplastic Anemia into Subclinical PNH/AA and Successful Treatment with Reduced Intensity Haplo-HSCT: A Pediatric Case Report

Clinical and Morphologic Predictors of Outcome in a Multicenter Cohort of ITP Patients Treated with Trombopoietin Analogues

Peroxiredoxin II ( PRDX2 ) Is a Novel Candidate Gene for Congenital Dyserythropoietic Anemia

Conservative Management of Idiopathic Hemophagocytic Lymphohistiocytosis (HLH) Achieving Complete Remission

RUNX1 associated Familial Platelet Disorder with Myeloid Malignancy (FPD-MM) in Children: A Novel New Phenotype with Juvenile and Chronic Myelomonocytic Leukemia (JMML/CMML) Characteristics

A Rare Case of Pearson's Syndrome with Predominant Hematological Manifestations and Novel Mitochondrial Deletion

Characterization of Iron Metabolism in Mouse Model of Congenital Polycythemia with Human Gain-of-Function Erythropoietin Receptor

Germline ERBB2 Variants Associate with Myeloproliferative Neoplasms

Efficacy of Lenalidomide in Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts

Clinical Significance of Myeloblasts Percentage in the De Novo Acute Myeloid Leukemia with Erythroid Hyperplasia

Therapeutic Outcomes of Patients with Acute Erythroid Leukemia Treated with Hypomethylating Agents

Quantification of Erythroblast- and Myelocyte-Derived mRNAs in Plasma Exosomes As an Indicator of Bone Marrow Status in Patients with Various Types of Anemias and Myeloproliferative Disorders

Myelodysplastic Syndromes (MDS) with Erythroid Hyperplasia: Enumerating Blasts from Non-Erythroid Cell Compartment Improves the Risk Stratification of MDS with Excess of Blasts

RAEB-1 with Erythroid Hyperplasia and Erythroleukemia Share Clinico-Biological Features and Outcome: A Same Disease with Different Labels?

A Germline Mutation in ERBB3 Predisposes to Inherited Erythroid Myelodysplasia/Erythroleukemia

Long Non-Coding RNA Induces De Novo Myelodysplastic Syndrome through Epigenetic Regulation

Biallelic Mutations in PARP4 Are Linked to a Variant Form of Congenital Dyserythropoietic Anemia

Gardos Channel Mutation Is Associated with Hereditary Dehydrate Stomatocytosis: a Complex Channelopathy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only